1 Bupivacaine-induced cardiotoxicity increases in hypoxic and acidotic conditions. We have analysed the eects of R(+)bupivacaine on hKv1.5 channels stably expressed in Ltk 7 cells using the whole-cell patch-clamp technique, at three dierent extracellular pH (pH o ), 6.5, 7.4 and 10.0. 2 Acidi®cation of the pH o from 7.4 to 6.5 decreased 4 fold the potency of R(+)bupivacaine to block hKv1.5 channels. At pH o 10.0, the potency of the drug increased *2.5 fold. 3 Block induced by R(+)bupivacaine at pH o 6.5, 7.4 and 10.0, was voltage-and time-dependent in a manner consistent with an open state block of hKv1.5 channels. 4 At pH o 6.5, but not at pH o 7.4 or 10.0, R(+)bupivacaine increased by 95+3 % (n=6; P50.05) the hKv1.5 current recorded at 710 mV, likely due to a drug-induced shift of the midpoint of activation (DV=78.5+1.4 mV; n=7). 5 R(+)bupivacaine development of block exhibited an`instantaneous' component of block at the beginning of the depolarizing pulse, which averaged 12.5+1.8% (n=5) and 4.6+1.6% (n=6), at pH o 6.5 and 7.4, respectively, and that was not observed at pH o 10.0. 6 It is concluded that: (a) alkalinization of the pH o increases the potency of block of R(+)bupivacaine, and (b) at pH o 6.5, R(+)bupivacaine induces an`agonist eect' of hKv1.5 current when recorded at negative membrane potentials.
Introduction
Bupivacaine is an amide type local anaesthetic widely used in regional anaesthesia. Unfortunately, bupivacaine is a very cardiotoxic local anaesthetic, likely due to its ability to decrease intracardiac conduction velocity, contractile force and sinoatrial activity (Strichartz, 1987) and to prolong QRS and QTc intervals of the ECG in anaesthetized dogs (Kasten & Martin, 1985; Wheeler et al., 1988) and human volunteers receiving high doses of bupivacaine (Scott et al., 1989) . These cardiac eects are the consequence of its blocking eects of Na + , Ca 2+ and several K + channels (Kv1.5, Kv2.1, Kv1.4, Kv4.3, HERG and KvLQT1+minK) (Clarkson & Hondeghem, 1985; Graf et al., 1997; Lipka et al., 1998; GonzaÂ lez et al., 2001) . Bupivacaine presents a chiral carbon and, thus, it can be separated into two enantiomers. It has been reported that bupivacaine-induced cardiotoxicity is mostly related to the eects of the R(+) enantiomer (A Ê berg, 1972; Luduena et al., 1972) . Bupivacaine induced block of cardiac Na + and hKv1.5 channels is stereoselective, being R(+)bupivacaine 1.6-and 7 fold more potent than S(7)-bupivacaine, respectively, whereas block of Kv2.1 and Kv4.3 is not (Valenzuela et al., 1995a, b; Franqueza et al., 1997; . It has been postulated that the cationic form of bupivacaine blocks hKv1.5 channels by binding to a receptor site located at the inner mouth of the channel involving, at least, the amino acids located at positions T505, L508 and V512 in the S6 segment of the channel (Valenzuela et al., 1995a; Franqueza et al., 1997) .
Changes in pH like those occurring during myocardial ischaemia, diabetic ketoacidosis, and respiratory acidosis due to hypoventilation alter the degree of protonation of an anaesthetic molecule and modulate both the therapeutic and the toxic eects of the drug (Strichartz, 1987) . In fact, bupivacaine-induced cardiotoxicity increased in hypoxic and acidotic conditions (Rosen et al., 1985; Nancarrow et al., 1987) . Acidosis increased the action potential duration in isolated guinea-pig ventricular muscle and isolated dog Purkinje ®bres, causing abnormal repolarization and early afterdepolarizations that were suggested to be due to a decrease in delayed rectifying potassium currents, supporting the idea that K + channel-mediated repolarization is impaired at low pH (Coraboeuf et al., 1976; Fry & Poole-Wilson, 1981; Bethell et al., 1998) . Recently, it has been demonstrated that Kv1.5 channels are sensitive to low extracellular pH changes like those occurring during myocardial ischaemia (Steidl & Yool, 1999) . Therefore, in this study we have analysed the possible dierences among the eects induced by R(+)bupivacaine on hKv1.5 channels due to changes in the extracellular pH values (pH o ) (6.5 and 10.0). Preliminary results of the present study have been published in abstract form (Longobardo et al., 1998) .
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Methods

Cell culture
Stably transfected Ltk 7 cells with the gene encoding the expression of hKv1.5 channels were cultured in DMEM supplemented with 10% horse serum and 0.25 mg ml 71 G418 (a neomycin analogue) under a 5% CO 2 atmosphere as previously described (Tamkun et al., 1991; Snyders et al., 1993) . Cultures were passaged every 3 ± 5 days by use of a brief trypsin treatment. Before experimental, subcon¯uent cultures were incubated with 2 mM dexamethasone for 24 h to induce expression of hKv1.5 channels. The cells were removed from the dish with a rubber policeman, a procedure that left the vast majority of the cells intact. The cell suspension was stored at room temperature (21 ± 238C) and used within 12 h for all the experiments reported.
Electrophysiological recording
Experiments were performed in a small volume (0.5 ml) bath mounted on the stage of an inverted microscope (Nikon model TMS, Garden City, NY, U.S.A.) perfused continuously at a¯ow rate of 0.5 ± 1.0 ml min
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. hKv1.5 currents were recorded at room temperature (21 ± 238C) using the whole-cell voltage-clamp con®guration of the patch-clamp technique (Hamill et al., 1981) with an Axopatch 1C patchclamp ampli®er (Axon Instruments, Foster City, CA, U.S.A.). Currents were ®ltered at 2 kHz (four-pole Bessel ®lter), sampled at 4 kHz, and stored on the hard disk of a Hewlett-Packard Vectra 486 computer for subsequent analysis. Data acquisition and command potentials were controlled by the PCLAMP 6.0.1 software (Axon Instruments). Micropipettes were pulled from borosilicate glass capillary tubes (Narishige, GD-1, Tokyo, Japan) on a programmable horizontal puller (Sutter Instrument Co., San Rafael, CA, U.S.A.) and heat-polished with a microforge (Narishige). The intracellular pipette ®lling solution contained (in mM): Kaspartate 80, KCl 50, phosphocreatine 3, KH 2 PO 4 10, MgATP 3, HEPES-K 10, EGTA 5 and was adjusted to pH 7.25 with KOH. The bath solution contained (in mM): NaCl 130, KCl 4, CaCl 2 1.8, MgCl 2 1, HEPES-Na 10, and glucose 10, and was adjusted to pH 6.50 or 7.40 with NaOH. In the experiments performed at extracellular pH 10.0, we used 10 mM CAPS-Na as buer. When ®lled with the intracellular solution and immersed into the bath (external solution), the pipette tip resistance ranged between 1 and 3 MO. The micropipettes were gently lowered onto the cells to obtain a gigaohm seal (17+3 GO) after applying suction. After seal formation, cells were lifted from the bottom of the perfusion bath and the membrane patch was ruptured with brief additional suction. The capacitive transients elicited by symmetrical 10-mV steps from 780 mV were recorded at 50 kHz (®ltered at 10 kHz) for subsequent calculation of capacitative surface area and access resistance (10.8+0.7 pF and 4.0+0.3 MO; n=10). Thereafter, capacitance and series resistence compensation were optimized, and 80% compensation of the eective access resistance was usually obtained, achieving a mean value of uncompensated access resistance of 2.2+0.2 MO (n=10). Since the mean maximum current recorded was 1.5+0.4 nA, the voltage error was under 5 mV (2.9+0.5 mV; n=10). Drugs R(+)bupivacaine (a gift from Astra, SoÈ dertaÈ lje, Sweden) was dissolved in distilled deionized water to yield stock solutions of 1 mM from which further dilutions were made to obtain the desired ®nal concentration.
Pulse protocol and analysis
The holding potential was maintained at 780 mV unless indicated otherwise. The eect of drug infusion was monitored with test pulses to +60 mV, applied every 30 s until steady-state was obtained. The cycle time for other pulse protocols was 10 s. Steady-state current-voltage relationships (IV) were obtained by averaging the current over a small window (2 ± 5 ms) at the end of 250 ms depolarizing pulses. Between 780 and 740 mV only passive linear leak was observed and least squares ®ts to these data were used for passive leak correction. Deactivating`tail' currents were recorded either at 740 mV (experiments performed at pH o 7.4 and 10.0) or 730 mV (experiments at pH o 6.5), in order to record deactivating tail currents at similar potentials within the activation of the channel. The activation curve was obtained from the tail current amplitude immediately after the capacitive transient. Measurements were done using the CLAMPFIT program of PCLAMP 6.0.1, Origin 5.0 (Microcal Software, Northampton, MA, U.S.A.) and by a custom-made analysis program.
Activation curves were ®tted with a Boltzmann equation:
in which s represents the slope factor, E the membrane potential and E h the voltage at which 50% of the channels are open. The activation kinetics of hKv1.5 have been described as a sigmoidal process (Snyders et al., 1993) . However, in the present study and in order to describe the dominant time constant of this process and the eects of drugs on it, the latter part of the current was ®tted to a single exponential, following a procedure previously described and used for the same purpose (Snyders et al., 1993; Valenzuela et al., 1994; DelpoÂ n et al., 1995) . Deactivation was ®tted to a biexponential process (Rich & Snyders, 1998) . Thus, this process was ®tted to an equation of the form:
where t 1 , and t 2 are the system time constants, A 1 , and A 2 are the amplitudes of each component of the exponential, and C is the baseline value. The curve-®tting procedure used a non-linear least-squares (Gauss-Newton) algorithm; results were displayed in linear and semilogarithmic format, together with the dierence plot. Goodness of ®t was judged by the w 2 criterion and by inspection for systematic non-random trends in the dierence plot. Drug-channel interactions were described by one or two binding curves. Apparent anity constant, K D , and Hill coecient, n H , for hKv1.5 channels at pH o 7.4 were obtained from ®tting the fractional block, f, at various drug concentrations [D] to one Hill curve:
where [D] is the drug concentration. Experimental data from hKv1.5 channels at pH o 6.5 and 10.0 were ®tted to the sum of two Hill equations:
where I 1 and I 2 are the fractional current of each component (I 1 +I 2 =1), K D1 and K D2 are the apparent dissociation constants and [D] has the same meaning as above. Apparent rate constants for binding (k) and unbinding (l) were obtained from solving:
Voltage dependence of block was determined as follows: leak-corrected current in the presence of drug was normalized to matching control to yield the fractional block at each voltage (f=17I drug /I control ). The voltage dependence of block was ®tted to:
where z, F, R and T have their usual meaning, d represents the fractional electrical distance, i.e., the fraction of the transmembrane electrical ®eld sensed by a single charge at the receptor site and K D * represents the apparent dissociation constant at the reference potential (0 mV). 
Statistical methods
Results
Effects of R(+)bupivacaine on hKv1.5 channels at pH o 6.5, 7.4 and 10.0 Figure 1A shows original records elicited at pH o 6.5, 7.4 and 10.0 in the absence and in the presence of R(+)bupivacaine by depolarizing pulses from a holding potential of 780 mV to +60 mV in steps of 10 mV. In the absence of drug, current rapidly activated during depolarization at +60 mV and the dominant time constant of this process was faster at more alkaline pH o [4.23+0.30 ms (n=20; P50.05), 2.10+0.20 ms (n=21) and 0.76+0.04 ms (n=13; P50.05) at pH o 6.5, 7.4 and 10.0, respectively]. After reaching a maximum peak value, hKv1.5 current slowly and partially inactivated during the application of the depolarizing pulse. (n=13), respectively. Table 1 shows the theoretical intracellular and extracellular concentrations of charged and uncharged R(+)bupivacaine after adding 5 mM R(+)bupivacaine to the external solution at pH o 6.5, 7.4 and 10.0. Whereas at pH o 6.5, the drug will be mostly present in its extracellular charged form; at pH o 10.0, the opposite will occur, so that the drug will accumulate inside the cell in its charged form (*39 mM). However, at pH o 7.4, similar concentrations of the cationic form of R(+)bupivacaine are expected at both sides of the cell membrane. Figure 1A shows hKv1.5 current records obtained in the absence and in the presence of equipotent concentrations of R(+)bupivacaine at the three pH o studied (20, 5 and 1 mM). It can be observed that the concentration required to induce a 50% block is reduced as the pH o is higher, which indicates that most of the blocking properties of R(+)bupivacaine on hKv1.5 channels are the consequence of its binding to a receptor site located at the inner mouth of the ion pore of the channel. In all cases, block induced by R(+)bupivacaine was time-dependent, inducing a fast initial decline at the beginning of the depolarizing pulse, suggestive of open channel block (Armstrong, 1971) . Therefore, steadystate block was measured at the end of 250 ms-depolarizing pulses from a holding potential of 780 mV to +60 mV. At pH o 6.5, 20 mM R(+)bupivacaine decreased hKv1.5 current by 62+4% (n=7), at pH o 7.4, 5 mM R(+)bupivacaine inhibited the current by 61+2% (n=5), and at pH o 10.0, R(+)bupivacaine (1 mM) inhibited hKv1.5 current by 47+5% (n=5). Therefore, acidi®cation of the pH o decreased 4 fold the potency of R(+)bupivacaine to block hKv1.5 channels while at pH o 10.0, the potency of the drug increased *2.5-fold versus the potency that it exhibits at the physiological pH o of 7.4 (Valenzuela et al., 1995a) . Figure 1B shows the activation curves of hKv1.5 channels obtained at the three pH o tested in the absence and in the presence of R(+)bupivacaine. Under control conditions, the midpoint of activation (E h ) of hKv1.5 channels was shifted to more positive membrane potentials as the pH o decreased [+3.1+0.7 mV (n=27; P50.05), 714.2+2.1 mV (n=38) and 723.1+1.3 mV (n=13; P50.05) at pH o 6.5, 7.4 and 10.0, respectively], without modi®cations in the slope factor [5.2+0.1 mV (n=27), 4.9+0.2 mV (n=38) and 4.6+0.2 mV (n=13) at pH o 6.5, 7.4 and 10.0]. In order to study the eects of the pH o on hKv1.5 channels, we represented the shift of the E h values against the pH o (Figure 2 ). Considering that DE h saturates at pH o 10.0, its value would be zero at this pH o . As it has been previously described for other ionic channels (Prod'hom et al., 1989; Ito et al., 1992; Yamane et al., 1993) , the E h shift of the activation of hKv1.5 channels induced by extracellular protons is consistent with a pKa value of 6.4, which is very close to the pKa of histidine (6.0). Therefore, these results suggest that titration of some histidine within the outer pore of hKv1.5 channels might be involved in this eect. As it is shown in Figure 1B , R(+)bupivacaine shifted the activation curve of hKv1.5 channels at the three pH o studied. However, this shift was only statistically signi®cant at pH o 6.5 (DV=78.5+1.4 mV, n=7; P50.01), whereas at pH o 7.4 and 10.0, R(+)bupivacaine at 5 and 1 mM only shifted the activation curves by 74.5+0.5 (n=6; P40.05) and 73.6+0.2 mV (n=7; P40.05), respectively. R(+)bupivacaine did not modify the slope factor of the activation curve under any experimental condition studied. Figure 3 shows the concentration-response curves obtained at pH o 6.5, 7.4 and 10.0. Although the concentration dependence for block of hKv1.5 channels at pH o 7.4 was adequately described by a single binding site model (Valenzuela et al., 1995a) , block induced by R(+)bupivacaine of hKv1.5 channels at pH o 6.5 or 10.0 was better ®t assuming two binding R(+)bupivacaine 20, 5 and 1 mM induced a time-dependent block which yields 62+4% (n=6), 61+2% (n=5) and 47+5% (n=5) at pH o 6.5, 7.4 and 10.0, respectively. (B) Shows the activation curves at pH o 6.5, 7.4 and 10.0 in the absence and in the presence of equipotent R(+)bupivacaine concentrations. The midpoint of activation (E h ) was shifted to more negative potentials as the pH o value was more alkaline. Data points represent the mean+s.e.mean of a 6 ± 7 experiments. *P50.01. Table 1 Left: concentration of neutral or charged R-bupivacaine inside and outside the cell after adding 5 mM R-bupivacaine to the external solution at dierent pH 0 . Right: concentration of charged R-bupivacaine (RB + ) inside and outside the cell membrane at the K D values obtained at pH 0 6.5, 7.4 and 10.0 (2) pH-Dependent effects of bupivacaine on hKv1.5 channels M. Longobardo et alsites, with the fraction of channels blocked with high anity being *30%, similarly to that previously described for R(+)-and S(7)-bupivacaine-block of some pore-mutant hKv1.5 channels (Franqueza et al., 1997) . A nonlinear least-squares ®t of the concentration-response equation (see Methods) to the individual data points yielded apparent K D's of 0.066+0.040 and 19.8+2.7 mM (n=39) for R(+)bupivacaine hKv1.5 block at pH o 6.5, and 0.027+0.007 and 1.7+0.2 mM (n=23) for R(+)bupivacaine block at pH o 10.0.
Intracellular concentrations Extracellular concentrations
Voltage-dependence of block of hKv1.5 channels by R(+)bupivacaine at different pH o Figure 4 shows the relative current obtained in the presence of equipotent concentrations of R(+)bupivacaine at the three pH o studied versus membrane potential. In all cases, block induced by R(+)bupivacaine steeply increased at the membrane potentials that coincided with the activation range of the channel, which strongly suggests that the drug binds to the open state of the channel. At membrane potentials positive to +10 mV (pH o =6.5), 0 mV (pH o =7.4) and 75 mV (pH o =10.0), block still increased but with a shallower voltage dependence. At this range of voltages the activation curve of the channel has reached saturation and, therefore, an increase of the degree of block cannot be attributed to an opening of the channel. Since R(+)bupivacaine is a weak base (pKa=8.1) this shallow voltage dependence of block was interpreted as the eect of the transmembrane electrical ®eld on the interaction between the cationic form of the drug and its receptor in the channel, according to a Woodhull model (Woodhull, 1973) . Therefore, ); where A represents the maximum amplitude, and assuming that E h saturates at pH o 10.0 (so DE h =0 at pH o =10.0), we calculated a pKa value of 6.44. This is in close agreement with the pKa value of protonation for an histidine (6.0) and suggests that the titration of a histidine present within the pore region of hKv1.5 channels could be responsible for the observed proton-induced shift towards more positive membrane potentials as the pH o is reduced. (2) pH-Dependent effects of bupivacaine on hKv1.5 channels M. Longobardo et ala nonlinear curve ®tting of the data to equation 6 (see Methods) yielded the fractional electrical distance (d) values that were 0.18+0.01 (n=14), 0.18+0.01 (n=5) and 0.16+0.01 (n=7) at pH o 6.5, 7.4 and 10.0, respectively. Figure 5 shows original hKv1.5 current traces recorded at very positive (+60 mV) and at the threshold for activation (710 mV) at pH o 6.5 in the absence and in the presence of R(+)bupivacaine. At this pH o value, R(+)bupivacaine (20 mM) decreased hKv1.5 current recorded at +60 mV by 62+4% (n=7; P50.01), but increased the hKv1.5 current amplitude at 710 mV, by 95+3% (n=6; P50.01). This increase was not signi®cant at pH o 7.4 (10+2%; n=6, P40.05, measured at 720 mV) and at pH o 10.0 only blocking eects could be observed (12+1%; n=5 P50.05, measured at 730 mV). The increase of the hKv1.5 current observed at negative membrane potentials at pH o 6.5 can be the consequence of a drug-induced negative voltage shift of the midpoint of the activation curve from +4.1+0.2 to 73.0+0.6 mV (n=7; P50.01). We will use the term`agonist eect' to describe the R(+)bupivacaine-induced increase of hKv1.5 current amplitude.
Time dependence of block of hKv1.5 channels by R(+)bupivacaine at different pH o
As it has been mentioned above, one of the most prominent eects of R(+)bupivacaine on hKv1.5 current at any pH o tested was the development of a fast initial decline at the beginning of the depolarizing pulse that was superimposed on the slow inactivation characteristic of the current ( Figure  6A ). The time constant of this initial decline was faster at higher drug concentrations and, therefore, it was taken as a good index of the time constant of the drug-channel interaction (t Block ). Figure 6B shows the apparent rate of block (t Block
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) versus R(+)bupivacaine concentrations at each pH o value. The straight lines are the least squares ®ts to the equation t Block 71 =k6[D]+l. Slope and intercept for ®tted relations yielded the apparent association (k) and dissociation (l) rates for R(+)bupivacaine at the three pH o studied. At pH o 6.5 the k value for R(+)bupivacaine was 3.7 fold smaller than that obtained at pH o 7.4. However, l values were similar at both pH o . The lower k value together with a similar l value calculated at pH o 6.5 can explain the lower potency of block induced by R(+)bupivacaine at pH o 6.5 compared to its potency at pH o 7.4 (K D =l/k). At pH o 10.0, both rate constants, k and l, were modi®ed compared to those calculated at pH o 7.4. Thus, while the k value was 9.1 fold times faster, the l value was only 3.1 fold times faster than values described at pH o 7.4. R(+)bupivacaine (1 mM) did not modify the activation time constant at pH o 10.0 [0.85+0.10 versus 0.72+0.08 ms (n=5; P40.05)] at +60 mV. However, at pH o 6.5 and 7.4 R(+)bupivacaine (10 and 5 mM; respectively) accelerated the activation time course of the current [2.59+0.17 ms versus 4.12+0.53 ms (n=5; P50.05) at pH o 6.5, and 1.45+0.11 ms versus 2.00+0.11 (n=6; P50.01) at pH o 7.4]. These results can suggest that, at pH o 6.5 and 7.4, R(+)bupivacaine may block some state of the hKv1.5 channel previous to the open one. In order to analyse this hypothesis we plotted the ratio between the drug-sensitive current and that recorded under control conditions [(I Control ± I Drug )/I Control ] at +60 mV versus time of depolarization (inset of Figure 6B ). As it can be observed, at pH o 6.5, R(+)bupivacaine development of block exhibited an`instantaneous' component of block at the beginning of the depolarizing pulse (t=0 ms), which averaged 12.5+1.8% (n=5). At pH o 7.4, a lower degree of instantaneous' block was observed (4.6+1.6%; n=6). At these two dierent pH o , block increased further during the application of the depolarizing pulses, indicating that R(+)bupivacaine binds also to the open state of the channel. At pH o 10.0 development of block began during the depolarization without an`instantaneous' component of block (n=5; P50.05 versus results obtained at pH o 6.5).
Time dependent block of hKv1.5 channels was also observed in the tail currents, which represent the transition from the open to the closed state of the channel. As it has been previously described, under control conditions, the deactivation of hKv1.5 channels recorded at 740 mV follows a biexponential function with fast and slow time constants that were similar at the three pH o values studied. If R(+)bupivacaine blocks hKv1.5 channels in the open state, as suggested by the time-and voltage-dependence block observed, then dissociation of R(+)bupivacaine from the blocked channels results in an open channel (which Figure 5 Eects of R(+)bupivacaine on hKv1.5 channels at pH o 6.5. Left panel shows original records obtained after depolarizing the cell from 780 to +60 mV. Right panel shows the drug eects after depolarizing the cell membrane to 710 mV. Note that, under these circumstances, the drug increased the amplitude of the hKv1.5 current by 95+3% (n=6; P50.05), whereas after strong depolarizations (left panel), R(+)bupivacaine inhibited the hKv1.5 current. subsequently could close). Blocked channels are not conducting, and the conversion to the open state should, therefore, result initially in a rising phase of the tail current; subsequently, the tail current should display a slower decline because some fraction of the open channels become blocked again, rather than closing irreversibly. Figure 7 shows the superposition of the tail currents obtained at 740 mV (pH o 7.4 and 10.0) or 730 mV (pH o 6.5) after a 250 ms depolarization to +60 mV under control conditions and in the presence of equipotent concentrations of R(+)bupivacaine at the three pH o . In all cases, R(+)bupivacaine slowed the time course of deactivation resulting in the`crossover' phenomenon (Figure 7) , which represents another piece of evidence supporting an open channel block mechanism (Armstrong, 1971) . At the three pH o studied, equipotent concentrations of R(+)bupivacaine (20, 5 and 1 mM) eliminated t f and therefore, the time course of deactivation followed a monoexponential function with time constants of 114.2+26.2 ms (n=4), 93.8+11.7 ms (n=6) and 95.1+13.6 ms (n=5), at pH o 6.5, 7.4 and 10.0, respectively.
Discussion
The main ®ndings of the present study are: (1) alkalinization of the pH o increases the potency of R(+)bupivacaine to block hKv1.5 channels at positive membrane potentials, consistent with the existence of an internal receptor bupivacaine site responsible of most of the blocking eects of R(+)bupivacaine. (2) R(+)bupivacaine at pH o 6.5 induces an`agonist eect' on hKv1.5 channels when recorded at negative membrane potentials (physiological membrane potentials).
Effects of pH o on hKv1.5 channels
As it has been previously described for other ion channels, changes in pH o modify the gating of hKv1.5 channels in a manner consistent with a surface screen of negative charges (Busch et al., 1991; Coulter et al., 1995; Fakler et al., 1996; Hoth et al., 1997) . In fact, a decrease or an increase of the pH o induced a positive or a negative shift in the E h of the activation curve, respectively. This suggests that protons . The solid line represents the linear ®t, from which the apparent binding and unbinding rate constants were obtained. Inset: Representative traces of time course of the development of block of hKv1.5 after a depolarizing pulse to +60 mV from a holding potential of 780 mV at pH o 6.5, 7.4 and 10.0 induced by R(+)bupivacaine at concentrations of 10, 5 and 1 mM, respectively. The reduction of hKv1.5 current in the presence of the drug is expressed as a proportion of the control current at any given time after the beginning of the depolarizing pulse. In the presence of R(+)bupivacaine at all the pH o studied inhibition of the current increases exponentially during depolarization. Note that at pH o 6.5 and 7.4, R(+)bupivacaine (10 mM) induced an instantaneous block at t=0 ms.
British Journal of Pharmacology vol 134 (2) pH-Dependent effects of bupivacaine on hKv1.5 channels M. Longobardo et aldecrease the negative charge at the external surface of the membrane, in the vicinity of the hKv1.5 channel gate and thus, alter the voltage ®eld sensed by the channel mechanism. The activation kinetics was also modi®ed by the pH o , being faster as the pH o increased, indicating that changes in the surface charges modify the kinetics of this channel, maybe due to a modi®cation of the channel gating. The pH odependent properties of dierent inwardly rectifying potassium channels and Kv1.3 channels have been attributed to the protonation of titrable amino acids such as histidine (Busch et al., 1991; Coulter et al., 1995; Hoth et al., 1997) , cysteine (Coulter et al., 1995) or lysine (Fakler et al., 1996) . Most of these amino acids are located near the outer part of the pore region. Recently, it has been demonstrated that the rat isoform of Kv1.5 channels (rKv1.5) is extremely sensitive to pH o (Steidl & Yool, 1999) . Protonation of a histidine located at position 452 in the pore region causes channels to accumulate in the C-type inactivated state inducing a reduction of Kv1.5 current amplitude (Steidl & Yool, 1999) . In the present study, the observed E h shift induced by extracellular protons is consistent with a pKa value of 6.4, which is very close to pKa of histidine (6.0). Since the human isoform of Kv1.5 channels (hKv1.5) exhibits an histidine at equivalent position to 452 in rKv1.5 channels, this amino acid might be responsible of the changes in E h .
R(+)bupivacaine blocks the open state of hKv1.5 channels at the three pH o studied
Block induced by R(+)bupivacaine at the three pH o studied was voltage dependent, consistent with a d value of *0.17 when measured from the inside of the membrane (Figure 4) . Also, at the three pH o studied, R(+)bupivacaine induced a fast initial decline of the maximum outward current upon depolarization from 780 to +60 mV, indicative of an open channel mechanism (Figure 6 ). Furthermore, R(+)bupivacaine slowed the deactivation process inducing a tail`crossover' phenomenon at all pH o studied ( Figure 7 ). All these results are consistent with an open channel block mechanism in which the cationic form of R(+)bupivacaine (RB + ) binds to a receptor located at the inner mouth of the ion pore of hKv1.5 channels blocking them when they achieve their open state (Valenzuela et al., 1995a; Franqueza et al., 1997) .
At pH o 6.5 and 7.4, R(+)bupivacaine induced an instantaneous block at t=0 ms that was not observed at pH o 10.0. This initial block, which appears before channel opening could be attributed to the drug interaction with a non conducting state of the channel. Consistent with this hypothesis, at pH o 6.5 and 7.4, R(+)bupivacaine accelerated the activation time constant at +60 mV vs that recorded in the absence of the drug in the same conditions.
As it can be observed in Figures 1, 3 and 6, acidi®cation of the pH o produced a 4 fold decrease in the potency of R(+)bupivacaine to block hKv1.5 channels when compared to data obtained at pH o 7.4. This lower potency could be attributed to a slower association time constant (k) for R(+)bupivacaine (the k value at pH o 7.4 was 3.7 times faster than at pH o 6.5), since the dissociation time constants (l) at the two pH o were similar. However, at pH o 10.0 the potency of R(+)bupivacaine to block hKv1.5 channels was 2.5 fold times higher than that described at pH o 7.4. This higher potency could be explained by the acceleration observed in the k value (9.1 fold times faster than that calculated at pH o 7.4) together with a 2.8 fold times faster l value.
Similarly to that reported for R(+)bupivacaine in blocking the¯icker K + channel present in thin myelinated nerve ®bres and in hKv1.5 mutated channels (T505I, T505S and T477S), at pH o 6.5 and 10.0, concentration-dependent block of hKv1.5 channels by R(+)bupivacaine best ®ts have been obtained under the assumption of two independent binding processes (Franqueza et al., 1997; Nau et al., 1999) . These ®ndings could be explained on the basis of the existence of two dierent populations of channels with dierent R(+)bupivacaine anity. However, this seems unlikely to occur with a cloned channel that forms homomultimers. Heteromultimer formation with endogenous subunits is also unlikely, since the Ltk 7 cells used do not contain endogenous voltage gated ion currents or detectable K + channel mRNA (Snyders et al., 1993) . A second possible explanation is that changes observed in channel gating observed in mutant channels or following changes in pH o may introduce a high-anity binding site for bupivacaine in hKv1.5 channels. However, if this would be the case, then all the current would be inhibited by the highanity binding site before the low-anity site could be occupied, thus masking low-anity binding. The hypothesis we favour is that even in wild type hKv1.5 channels multiple (Gingrich et al., 1993) . Under this framework, hKv1.5 channels with a modi®ed gating induced by changes in pH o would be stabilizing an ultrafast (higher anity) interaction between bupivacaine and hKv1.5 channels. In fact, there is evidence that multiple open states exist in hKv1.5 channels and that conversion between them can be in¯uenced by drug concentration (Rich, 1996) . Thus, as bupivacaine concentration increases, an open state with low anity is favoured. This hypothesis requires a drug-induced shift in gating that is independent of open-channel block, such as that observed at pH o 6.5. Thus, at pH o 6.5 and 10.0, conformational changes induced by a higher or a lower proton concentration would promote a drug-induced shift in channel gating that reveal an open state with lower anity for bupivacaine. However, the mechanism responsible for the biphasic dose-response curves requires further investigation.
Possible contribution of R(+)bupivacaine-binding to the external binding site to the total block induced on hKv1.5 channels It has been generally accepted that the blocking eects of R(+)bupivacaine were mostly due to the interaction between the intracellular cationic form of the drug with the inner mouth of the ion pore (Valenzuela et al., 1995a; Franqueza et al., 1997) (Longobardo et al., 2000) . Therefore, these results may suggest that the relative contribution of R(+)bupivacaine-binding to the external receptor site to the total block observed is prominent at pH o 6.5, less important at pH o 7.4 and almost negligible at pH o 10.0. As mentioned above, it has been described that at pH 6.2, the protonation of a histidine at position 452 of Kv1.5 channels, induces the channels to accumulate in the inactivated state (Steidl & Yool, 1999) . In addition, we have described that binding of a permanently charged bupivacaine analog to the internal bupivacaine receptor site modi®es the eects induced by the permanently charged analogue extracellularly applied (RB + 1C out ) when the experimental conditions promote the inactivated state of the channel (long depolarizing pulses) (Longobardo et al., 2000) . In fact, the degree of block induced by RB + 1C out was higher in the presence of RB + 1C at the internal side of the membrane at the end of a 4 s depolarizing pulse than in the absence of drug in the intracellular media. Therefore, a possible explanation for the observed increased block at lower [RB + ] in (observed at pH o 6.5) could be the functional coupling between both receptor sites.
Agonist effects of R(+)bupivacaine at pH o 6.5
During the application of 250 ms depolarizing pulses from 780 mV to +60 mV, R(+)bupivacaine blocked hKv1.5 channels at the three pH o studied. However, at membrane potentials close to the threshold for channel activation, R(+)bupivacaine eects were dierent depending on the pH o value. At low pH o , at which the concentration of the extracellular cationic form of the drug is much higher, we observed an agonist eect at negative potentials (710 mV) that was not observed neither at pH o 7.4 nor at pH o 10.0. This eect was likely due to the drug-induced shift of the activation curve to more negative potentials, as it has been described for other potassium channels and drugs (Carmeliet, 1993; Tseng et al., 1996; Davies et al., 1996; DelpoÂ n et al., 1999) . At pH o 6.5, drug is mostly present in its cationic form at the external side of the membrane, which may suggest that it is the charged form of bupivacaine the one which exherts the`agonist eect' by binding to the receptor site located at the external side of the membrane. On the other hand, bupivacaine is a very hydrophobic drug with a lipid phase/ aqueous phase partition coecient (logP) of 4.0. Given its pKa value (8.1), the lipid/buer distribution coecient (logQ) is 2.4, 3.2 and 4.0 at pH o 6.5, 7.4 and 10.0, respectively. These values predict that drug concentration at the cell membrane will increase 240, 320 and 400 fold at pH o 6.5, 7.4 and 10.0, respectively. Thus, at the K D values calculated for these pH o values, the theoretical expected drug concentration at the cell membrane will be 4560, 1504 and 6783 mM, respectively. Therefore, we cannot rule out the possibility that the uncharged form of the drug would be responsible of the observed shift in the activation curve. In fact, it has been described that neutral local anaesthetics, such as benzocaine, induce, at low concentrations, similar eects on these potassium channels (DelpoÂ n et al., 1999) Possible clinical consequences of the present study It has been described that bupivacaine cardiotoxicity increases in acidosis and hypoxia (Rosen et al., 1985; Nancarrow et al., 1987) . During acidosis, most ionic currents, including hKv1.5, I Na , I Ca , I TO , I Kr and I Ks , are inhibited by extracellular protons (Prod'hom et al., 1989; Zhang & Siegelbaum, 1991; Yamane et al., 1993; Stengl et al., 1998; Anumonwo et al., 1999; Steidl & Yool, 1999) . These eects on ion channels are translated, at the multicellular level, into a depolarization of the membrane potential, a reduction of conduction velocity, and a prolongation of the action potential duration, with eventual oscillations at the plateau level and occurrence of early afterdepolarizations (Coraboeuf et al., 1980; Cordeiro et al., 1994) . Bupivacaine not only blocks hKv1.5 channels, but also those responsible of the activation of I Kr , I Ks and I TO (Castle, 1990; Lipka et al., 1998; Franqueza et al., 1999; GonzaÂ lez et al., 2001) . Therefore, a further decrease of hKv1.5 current, would be expected to be accompanied by a prolongation of the atrial action potential, which could be, together with its eects on other K + currents, responsible of the higher bupivacaine cardiotoxicity.
However, the increased bupivacaine cardiotoxicity at low pH o would also involve its blocking eects on cardiac Na + channels. In fact, under these conditions, the resting membrane potential is depolarized to levels which promote the transition of Na + channels from the rested to the inactivated state, which makes them more susceptible to be blocked by bupivacaine (Clarkson & Hondeghem, 1985; Valenzuela et al., 1995b) , and, as a consequence, the conduction velocity will decrease to a higher extent, contributing to the observed higher cardiotoxicity.
Conclusions
In this study, we demonstrated that R(+)bupivacaine potency to block hKv1.5 channels increases in parallel with the increase in the pH o and, thus, with the increase in the intracellular concentration of the cationic form of the drug. Also, at low pH o (6.5), R(+)bupivacaine increases hKv1.5 current at negative membrane potentials, likely due to the drug induced shift of the activation curve. At the K D values, intracellular concentrations of the cationic form of R(+)bupivacaine do not match at the dierent pH o , suggesting that either: (a) binding to the extracellular bupivacaine binding site, or (b) the in¯uence of hKv1.5 channel inactivation, that predominates at low pH o , might determine the blocking eects of R(+)bupivacaine on hKv1.5 channels.
